National Institutes of Health and 187 Osong Saengmyeong2 ro

Mungyeong, South Korea

National Institutes of Health and 187 Osong Saengmyeong2 ro

Mungyeong, South Korea

Time filter

Source Type

Kim J.Y.,National Institutes of Health and 187 Osong Saengmyeong2 ro | Park K.J.,National Institutes of Health and 187 Osong Saengmyeong2 ro | Kim G.H.,National Institutes of Health and 187 Osong Saengmyeong2 ro | Jeong E.A.,National Institutes of Health and 187 Osong Saengmyeong2 ro | And 7 more authors.
Cellular Signalling | Year: 2013

In obese Zucker diabetic fatty (ZDF) rats, ER stress is associated with insulin resistance and pancreatic β-cell dysfunction; however the exact mechanisms by which ER stress drives type-2 diabetes remain uncertain. Here, we investigated the role of ATF3 on the preventive regulation of AMPK against ER stress-mediated β-cell dysfunction during the end-stage progression of hyperglycemia in ZDF rats. The impaired glucose metabolism and β-cell dysfunction were significantly increased in late-diabetic phase 19-week-old ZDF rats. Although AMPK phosphorylation reduced in 6- and 12-week-old ZDF rats was remarkably increased at 19. weeks, the increases of lipogenice genes, ATF3, and ER stress or ROS-mediated β-cell dysfunction were still remained, which were attenuated by in vivo-injection of chemical chaperon tauroursodeoxycholate (TUDCA), chronic AICAR, or antioxidants. ATF3 did not directly affect AMPK phosphorylation, but counteracts the preventive effects of AMPK for high glucose-induced β-cell dysfunction. Moreover, knockdown of ATF3 by delivery of in vivo-jetPEI ATF3 siRNA attenuated ER stress-mediated β-cell dysfunction and enhanced the beneficial effect of AICAR. Our data suggest that ATF3 may play as a counteracting regulator of AMPK and thus promote β-cell dysfunction and the development of type-2 diabetes and could be a potential therapeutic target in treating type-2 diabetes. © 2013 Elsevier Inc.


PubMed | National Institutes of Health and 187 Osong Saengmyeong2 ro
Type: Journal Article | Journal: Cellular signalling | Year: 2013

In obese Zucker diabetic fatty (ZDF) rats, ER stress is associated with insulin resistance and pancreatic -cell dysfunction; however the exact mechanisms by which ER stress drives type-2 diabetes remain uncertain. Here, we investigated the role of ATF3 on the preventive regulation of AMPK against ER stress-mediated -cell dysfunction during the end-stage progression of hyperglycemia in ZDF rats. The impaired glucose metabolism and -cell dysfunction were significantly increased in late-diabetic phase 19-week-old ZDF rats. Although AMPK phosphorylation reduced in 6- and 12-week-old ZDF rats was remarkably increased at 19weeks, the increases of lipogenice genes, ATF3, and ER stress or ROS-mediated -cell dysfunction were still remained, which were attenuated by in vivo-injection of chemical chaperon tauroursodeoxycholate (TUDCA), chronic AICAR, or antioxidants. ATF3 did not directly affect AMPK phosphorylation, but counteracts the preventive effects of AMPK for high glucose-induced -cell dysfunction. Moreover, knockdown of ATF3 by delivery of in vivo-jetPEI ATF3 siRNA attenuated ER stress-mediated -cell dysfunction and enhanced the beneficial effect of AICAR. Our data suggest that ATF3 may play as a counteracting regulator of AMPK and thus promote -cell dysfunction and the development of type-2 diabetes and could be a potential therapeutic target in treating type-2 diabetes.

Loading National Institutes of Health and 187 Osong Saengmyeong2 ro collaborators
Loading National Institutes of Health and 187 Osong Saengmyeong2 ro collaborators